These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6076702)

  • 21. [Value of serum-cholinesterase-activity determination in hepato-biliary disease].
    Delubac F; Chevrel B; Touboul JP; Bretaudiere JP
    Med Chir Dig; 1977; 6(3):159-62. PubMed ID: 895243
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum 5'nucleotidase activity in hepatobiliary diseases].
    Cortés Rius M; Ferragút Canals A; Simón Lamuela MA; Gosalvez AM; Esque Bernadas C; Concustell Bas E
    Rev Clin Esp; 1975 Jul; 138(2):137-41. PubMed ID: 1178958
    [No Abstract]   [Full Text] [Related]  

  • 23. [Changes in enzyme activity in chronic liver and biliary tract diseases treated at the Mirgorod health resort].
    Guba NM; Kuchma AP; Vershinskaia NV; Guba MI
    Vrach Delo; 1981 Sep; (9):88-91. PubMed ID: 7303625
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum gamma glutamyltranspeptidase activity in diseases of the liver and gallbladder (except infectious jaundice).
    Dimov DM
    Vnitr Lek; 1969 Apr; 15(4):347-53. PubMed ID: 5780937
    [No Abstract]   [Full Text] [Related]  

  • 25. [A modification of the method of determining alkaline phosphatase activity for the diagnosis of diseases of the liver and bile ducts].
    Kolmakov VN; Kuleba VA; Chamin NN
    Sov Med; 1968 Aug; 31(8):58-61. PubMed ID: 5733428
    [No Abstract]   [Full Text] [Related]  

  • 26. [Urinary enzyme determinations in hepatobiliary diseases].
    Burchardt U; Peters JE; Thulin H
    Z Gesamte Inn Med; 1973 Sep; 28(17):271-2 contd. PubMed ID: 4767184
    [No Abstract]   [Full Text] [Related]  

  • 27. [Contribution of the General Hospital of the National Medical Center to medicine. II. Enzyme changes in liver diseases].
    Landa L; Lee E; Guerrero M; Sepúlveda B
    Gac Med Mex; 1967 Jul; 97(7):857-64. PubMed ID: 5611571
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative studies on the behavior of alkaline phosphatase, leucylaminopeptidase and gamma-glutamyltranspeptidase in the diseases of the bile ducts and liver].
    Cichecka K; Drozdz H; Jedrychowski A
    Pol Tyg Lek; 1970 Jul; 25(28):1037-9. PubMed ID: 5456851
    [No Abstract]   [Full Text] [Related]  

  • 29. [Laboratory diagnosis of liver diseases].
    Wiek K
    Med Lab (Stuttg); 1971 Oct; 24(10):217-21. PubMed ID: 5096210
    [No Abstract]   [Full Text] [Related]  

  • 30. [Enzyme diagnosis and therapy in surgery].
    Gürtner T
    Med Monatsschr; 1967 Nov; 21(11):489-94. PubMed ID: 5306165
    [No Abstract]   [Full Text] [Related]  

  • 31. Histochemical changes in the dog liver after common bile-duct ligation.
    Georgiades D; Merikas G; Hadziyannis S; Agapitidis N
    J Pathol Bacteriol; 1967 Apr; 93(2):677-81. PubMed ID: 6054063
    [No Abstract]   [Full Text] [Related]  

  • 32. [Certain glycolytic enzymes of blood serum in patients with pathology of the biliary tract].
    Podil'chak MD; Podil'chak EM
    Klin Med (Mosk); 1973 Oct; 51(10):91-4. PubMed ID: 4787287
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in amylase activities in diseases of the liver and the bile duct, with special reference to isozyme activities].
    Ono T; Eto K
    Igaku To Seibutsugaku; 1970 Oct; 81(4):193-6. PubMed ID: 5531571
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical significance of serum gamma-GTP isoenzymes].
    Kojima J
    Rinsho Byori; 1982 Aug; 30(8):854-60. PubMed ID: 6129335
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental and clinical studies on increase of gammaglutamyltranspeptidase activity in serum in hepathobiliary diseases].
    Thiele KG; Holmes AW; Mattenheimer H
    Verh Dtsch Ges Inn Med; 1973; 79():925-7. PubMed ID: 4151322
    [No Abstract]   [Full Text] [Related]  

  • 36. In situ monitoring of caspase activation in hepatobiliary diseases.
    Bantel H; Ruck P; Schulze-Osthoff K
    Cell Death Differ; 2000 May; 7(5):504-5. PubMed ID: 10917736
    [No Abstract]   [Full Text] [Related]  

  • 37. Alkaline phosphatase in bile and urine. Excretion in patients with hepatobiliary disease.
    Allen H; Spellberg MA
    Arch Intern Med; 1967 Dec; 120(6):667-71. PubMed ID: 6058402
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical studies on serum sorbitol dehydrogenase.
    Lin C
    Nihon Naika Gakkai Zasshi; 1971 May; 60(5):387-98. PubMed ID: 5165470
    [No Abstract]   [Full Text] [Related]  

  • 39. Lecithin: cholesterol acyltransferase levels in plasma of patients with hepatobiliary disease.
    Palacios Beristáin O; Vázquez I; Segovia Balmes E
    Arch Invest Med (Mex); 1984; 15(2):155-62. PubMed ID: 6487005
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study of the alkaline phophatase and 5-nucleotidase activity of the serum. Clinical and experimental results].
    Housset E; Etienne JP ETITE JP
    Rev Int Hepatol; 1967 May; 17(6):519-36. PubMed ID: 5585947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.